Data as of Mar 06
| -0.35 / -2.30%|
The 7 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 25.00 and a low estimate of 14.00. The median estimate represents a +34.23% increase from the last price of 14.90.
The current consensus among 7 polled investment analysts is to Buy stock in Momenta Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.